Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02295007 · ClinicalTrials.gov registry record · NA
Fever and Wheezing Events in Children After US Influenza Vaccines Using Text Messaging
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 266
- Enrollment target
NCT02295007 is a NA study that has completed, run by Columbia University. The registered enrollment target is 266 participants.
The verdict
NCT02295007, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 266 participants
- Enrollment target
Study Summary
Children 2-11 years of age who are given the influenza vaccine (inactivated influenza (IIV) or live attenuated influenza vaccine (LAIV)) as part of their routine care can enroll in this study if their parent has the ability to receive and send text messages. Children enrolled in this study will be observed daily for an eight-day period starting on the day of vaccine administration, and then continuing over the next 7 days, and then weekly for 42 days. On the day of enrollment and nightly for the next seven days, the parent will report via text message what their child's highest temperature is. If fever is present, they will then be prompted for additional information including other symptoms, antipyretic use and medical care sought. On day 3 as well as weekly from day 7 through day 42 post-vaccination, parents will be asked via text message about breathing problems, specifically cough, wheezing and chest tightness. They will also be asked about medications taken and care sought. The purpose of this study is to assess the feasibility of collecting this data.
Interventions
- BEHAVIORAL text message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02295007
The ClinicalTrials.gov registry entry for NCT02295007 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 266 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which text message is the first listed.
NCT02295007 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02295007 about?
NCT02295007 is a clinical study titled "Fever and Wheezing Events in Children After US Influenza Vaccines Using Text Messaging". Children 2-11 years of age who are given the influenza vaccine (inactivated influenza (IIV) or live attenuated influenza vaccine (LAIV)) as part of their routine care can enroll in this study if their parent has the ability to receive and send text messages. Children enrolled in this study will be o...
What is the current status of trial NCT02295007?
This trial is currently completed. It is a NA study. The enrollment target is 266 participants. The study started on 2014-12. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02295007?
The interventions under investigation include: text message (BEHAVIORAL).
Who is sponsoring clinical trial NCT02295007?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.